These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6872340)

  • 1. Stable E rosette-forming lymphocytes in the peripheral blood in non-Hodgkin's lymphoma.
    Markey GM; Alexander HD; Hayes DM; Robertson JH; Morris TC
    Clin Immunol Immunopathol; 1983 Feb; 26(2):162-70. PubMed ID: 6872340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the high- and low-affinity rosette-forming T-lymphocytes in patients with Hodgkin's and non-Hodgkin's lymphoma.
    Kadhim S; Rees RC; Potter CW; Walker R; Hancock BW
    Eur J Cancer (1965); 1981 May; 17(5):569-75. PubMed ID: 6975211
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical significance of autorosette-forming cells in T-cell lymphoma.
    Tamura K; Aratake Y; Endo Y; Ohtaki S
    Leuk Res; 1984; 8(2):275-83. PubMed ID: 6609283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological characterization of non-Hodgkin's lymphoma: enrichment of neoplastic cells from lymphoid tissues and blood.
    Bom-Van Noorloos AA; Van Beek AA; Ubels-Postma J; Zeijlemaker WP; Van Heerde P; Von Dem Borne AE; Cleton FJ; Melief CJ
    Cancer; 1982 Apr; 49(8):1605-12. PubMed ID: 6978173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double test of spontaneous rosettes with sheep and mouse erythrocytes. Statistical studies and usefulness in malignant evolutive and nonevolutive lymphoproliferative diseases.
    Beaumariage ML; Focan C
    Acta Haematol; 1978; 59(6):321-31. PubMed ID: 97890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal peripheral blood lymphocytes and bone marrow infiltration in non-Hodgkin's lymphoma.
    Garrett JV; Scarffe JH; Newton RK
    Br J Haematol; 1979 May; 42(1):41-50. PubMed ID: 380628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of lymphocytes forming stable E-rosettes generated in vivo and in vitro.
    Wansbrough-Jones MH; Scullard GH; Eddleston AL; Williams R
    J Clin Lab Immunol; 1980 May; 3(3):171-3. PubMed ID: 6968354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocompetent cells in malignant disease in man. II. Clinical and immunologic correlates in a case of non-Hodgkin's lymphoma.
    Algom D; Rapp E; Hamdy H; Keaney MA; Hirte W; Klaassen DJ; Richter M
    Can Med Assoc J; 1978 Jan; 118(2):168-71. PubMed ID: 757385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal studies of blood lymphocyte functions in non-Hodgkin's lymphoma.
    Simonsson-Lindemalm C; Biberfeld P; Björkholm M; Holm G; Johansson B; Mellstedt H; Nilsson B; Ost A
    Eur J Cancer Clin Oncol; 1983 Jun; 19(6):747-55. PubMed ID: 6683648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune deficiency in Hodgkin and non-Hodgkin lymphoma.
    El-Haddad SI; El-Ashmawy S; Hassan W; George E; Ali FM; Sharaf MA; Mahfouz M
    Biomedicine; 1980 Oct; 32(3):128-33. PubMed ID: 7448322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosette-forming cells in patients with treated leprosy.
    Dang DT; Pham MH; Hoang TL; Lai VG; Nguyen HH
    Int J Lepr Other Mycobact Dis; 1983 Jun; 51(2):174-8. PubMed ID: 6684644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic significance of lymphocytes forming "active rosettes" in lung cancer].
    Youinou P; Clavier J; Guillerm D; Miossec P; Kerbrat G
    Rev Fr Mal Respir; 1982; 10(6):409-16. PubMed ID: 7163596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Reed-Sternberg cell/lymphocyte rosette. I. Properties of rosettes formed between Hodgkin's cell lines and allogeneic lymphocytes.
    Flavell DJ; Wright DH
    Br J Cancer; 1989 Feb; 59(2):165-73. PubMed ID: 2495015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosette-formation with mouse red blood cells in chronic lymphocytic leukemia and leukemic non-Hodgkin's lymphomas.
    Wirthmüller R; Gerhartz H
    Klin Wochenschr; 1980 Jul; 58(14):743-5. PubMed ID: 7453087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple method for electronic counting of rosette forming human blood lymphocytes.
    Sandberg G; Björkholm M
    Clin Exp Immunol; 1985 Feb; 59(2):499-504. PubMed ID: 3978877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, hematologic, and pathologic features of leukemic T-cell lymphoma.
    Kinoshita K; Kamihira S; Ikeda S; Yamada Y; Muta T; Kitamura T; Ichimaru M; Matsuo T
    Cancer; 1982 Oct; 50(8):1554-62. PubMed ID: 6981451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosette and blastogenesis inhibition by plasma from Hodgkin's disease and other malignancies. Positive correlation in State I and II Hodgkin's disease.
    Sinclair T; Ezdinli EZ; Boonlayangoor P; Wasser LP; Han T
    Cancer; 1983 Jan; 51(2):238-44. PubMed ID: 6336976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-rosette inhibiting substance in Hodgkin's disease spleen extracts.
    Bieber MM; Fuks Z; Kaplan HS
    Clin Exp Immunol; 1977 Sep; 29(3):369-75. PubMed ID: 201408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal active rosette-forming-cells in untreated patients with Hodgkin's disease.
    Lang JM; Bigel P; Oberling F; Mayer S
    Biomedicine; 1977 Dec; 27(9-10):322-4. PubMed ID: 606306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    Fuks Z; Strober S; Kaplan HS
    N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.